Sage Journals: Discover world-class research

Abstract

Get full access to this article

View all access options for this article.

References

Graff

Dallara

Ross

. Impact on the care of the emergency department chest pain patient from the Chest Pain Evaluation Registry (CHEPER) Study. Am J Cardiol 1997; 80:563–8.

Vanmiltenburg

AJM

Simoons

Veerhoek

Bossuyt

PMM

. Incidence and follow up of Braunwald sub groups in unstable angina pectoris. J Am Coll Cardiol 1995; 25:1286–92.

Rizik

Healy

Margulis

. A new clinical classification for hospital prognosis of unstable angina. Am J Cardiol 1995; 75:993–7.

Rupprecht

Sohn

Kearney

. Clinical predictors of unstable coronary lesion morphology. Eur Heart J 1995; 16:1526–34.

Dangas

Mehran

Wallenstein

. Correlation of angiographic morphology and clinical presentation in unstable angina. J Am Coll Cardiol 1997; 29:519–25.

Owa

Origasa

Saito

. Predictive validity of the Braunwald Classification of unstable angina for angiographic findings, short term prognoses, and treatment selection. Angiology 1997; 48:663–71.

Cannon

McCabe

Stone

. The electrocardiogram predicts one year outcome of patients with unstable angina and non Q wave myocardial infarction: Results of the TIMI III registry ancillary study. J Am Coll Cardiol 1997; 30:133–40.

Patel

Holdright

Knight

. Early continuous ST segment monitoring in unstable angina: prognostic value additional to the clinical characteristics and the admission electrocardiogram. Heart 1996; 75:222–8.

Stevenson

Marchant

Ranjadayalan

. Holter ST monitoring early after acute myocardial infarction - mechanisms of ischaemia in patients treated by thrombolysis. Br Heart J 1993; 70:433–7.

10.

Summaria

Liuzzo

Petrone

. Increased levels of C-reactive protein and serum amyloid A protein are related to a raised risk of new coronary events within one year in patients with unstable angina. Circulation 1997; 96:1270.

11.

Oltrona

Ardissino

Merlini

. C reactive protein elevation and early outcome in patients with unstable angina pectoris. Am J Cardiol 1997; 80:1002–6.

12.

Noto

Johnson

Krone

. Cardiac catheterization 1990: a report of the Registry of the Society of Cardiac Angiography and Interventions. Cathet Ccardiovasc Diagn 1991; 24:75–83.

13.

de Bono

. Complications of diagnostic cardiac catheterisation: results from 34,041 patients in the United Kingdom confidential inquiry into cardiac catheter complications. Br Heart J 1993; 70:297–300.

14.

Kern

. Selection of radiocontrast media in cardiac catheterisation: comparative physiology and clinical effects of nonionic monomeric and ionic dimeric formulations. Am Heart J 1991; 122:195–201.

15.

Pasternak

Thibault

Savoia

. Chest pain with angiographically insignificant arterial obstruction: clinical presentation and long term follow up. Am J Med 1980; 68:813–7.

16.

Pitts

Lange

Cigarroa

Hillis

. Repeat coronary angiography in patients with chest pain and previously normal coronary angiogram. Am J Cardiol 1997; 80:1086–7.

17.

Oler

Whooley

Oler

Grady

. Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina - a meta analysis. J Am Med Assoc 1996; 276:811–5.

18.

Serneri

GGN

Modesti

Gensini

. Randomized comparison of subcutaneous heparin, intravenous heparin and aspirin in unstable angina. Lancet 1995; 345:1201–4.

19.

Cohen

Demers

Gurfinkel

. A comparison of low molecular weight heparin with unfractionated heparin for unstable coronary disease. N Engl J Med 1997; 337:447–52.

20.

Klein

Buchwald

Hillis

. Comparison of low molecular weight heparin acutely with placebo for six weeks in the management of unstable coronary artery disease - Fragmin in unstable coronary artery disease study (FRIC). Circulation 1997; 96:61–8.

21.

Grip

Frison

Wallentin

. A low molecular weight selective thrombin inhibitor, inogatran, vs heparin, in unstable coronary artery disease. Eur Heart J 1997; 18:1416–25.

22.

Wallentin

Ohlsson

Swahn

. Low molecular weight heparin during instability in coronary artery disease. Lancet 1996; 347:561–8.

23.

Mark

Cowper

Berkowitz

. Economic assessment of low molecular weight heparin (Enoxaparin) versus unfractionated heparin in acute coronary syndrome patients. Circulation 1998; 97:1702–7.

24.

Fuchs

Cannon

Braunwald

, TIMI 7 Investigators Hirulog in the treatment of unstable angina: results of the Thrombin Inhibition in Myocardial ischaemia (TIMI) 7 Trial. Circulation 1995; 92:727–33.

25.

Antman

. Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B Trial. Circulation 1996; 94:911–21.

26.

Topol

Califf

Granger

. A comparison of recombinant hirudin with heparin for the treatment of acute coronary symdromes. New Engl J Med 1996; 335:775–82.

27.

Bata

MacFarlane

Campeau

. Comparison of the effects of two doses of recombinant hirudin compared with heparin in patients with acute myocardial ischaemia without ST elevation - a pilot study. Circulation 1997; 96:769–77.

28.

Antiplatelet Trialists Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. I Prevention of death myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308:81–106.

29.

Schafer

. Antiplatelet therapy. Am J Med 1996; 101:199–209.

30.

Wheeldon

Cumberland

. Pharmcologic prevention of acute ischemic complications of coronary angioplasty. Cathet Cardiovasc Diagn 1997; 42:249–56.

31.

Born

GVR

Collins

. Aspirin versus clopidogrel: the wrong question? Lancet 1997; 349:806–7.

32.

Gent

Beaumont

Blanchard

. A randomized blinded trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). Lancet 1996; 348:1329–39.

33.

Coller

Anderson

Weisman

. The anti GPIIb/IIIa agents: fundamental and clinical aspects. Haemostasis 1996; 26:285–93.

34.

Theroux

Fung

Boudreault

. Platelet membrane receptor glycoprotein IIb/IIIa antagonism in unstable angina - The Canadian Lamifiban study. Circulation 1996; 94:899–905.

35.

Pepine

Cohn

Deedwania

. Effects of treatment on outcome in mildly symptomatoc patients with ischaemia during daily life. The Atenolol Silent Ischaemia Study (ASSIST). Circulation 1994; 90:762–8.

36.

Grundy

. Statin trials and goals of cholesterol lowering therapy. Circulation 1998; 97:1436–9.

37.

Gotto AM AFCAPS/TEXCAPS Interim Study results. American Heart Association, November 1997

38.

Tonkin

. LIPID Interim Study results. American Heart Association, November 1997.

39.

Andrews

Raby

Barry

. Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease. Circulation 1997; 95:324–8.

40.

McCormick

Black

Waters

. Rationale, design and baseline characteristics of a trial comparing agressive lipid lowering with atorvastatin versus revascularization treatments (AVERT). Am J Cardiol 1997; 80:1130–3.

41.

Braunwald

McCabe

Cannon

. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non Q wave myocardial infarction: results of the TIMI III B Trial. Circulation 1994; 89:1545–56.

42.

Rickards

Ilsley

Simon

. First year results of CABRI. Lancet 1995; 346:1179–84.

43.

Hlatky

Rogers

Johnstone

. Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. N Engl J Med 1997; 336:92–9.

44.

Boden

O'Rouke

Dai

. Improved clinical outcomes in non Q wave infarction patients randomized to a conservative ischemia guided strategy compared to an invasive/interventional strategy: results of the multicenter VA non Q wave infarction strategies in hospital (VANQWISH) trial. Circulation 1997; 96:1145.

45.

Sigwart

. Joint AHA/ESC symposium: new insights into unstable angina and non ST elevation - results of treatment by PTCA and CABG, Plenary Session III 70th Scientific Sessions of the American Heart Association, Orlando Fl. November 1997.

46.

Parker

Gray

Balcon

. Planning for coronary angioplasty: guidelines for training and continuing competence. Heart 1996; 75:419–25.

The Evolving Management of Unstable Coronary Artery Disease and Its Impact on Practice Outwith the Tertiary Hospital

Abstract

Get full access to this article

References